Business Description

Kodiak Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US50015M1099
Compare
Compare
Traded in other countries / regions
K27.GermanyKOD.MexicoKOD.USA IPO Date
2018-10-04Description
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.86 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | -0.3 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -71.4 | |||||
3-Year EPS without NRI Growth Rate | -72.3 | |||||
3-Year FCF Growth Rate | -66.8 | |||||
3-Year Book Growth Rate | 2.3 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 83.21 | |||||
9-Day RSI | 76.38 | |||||
14-Day RSI | 71.74 | |||||
6-1 Month Momentum % | -42.36 | |||||
12-1 Month Momentum % | -45.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.25 | |||||
Quick Ratio | 6.25 | |||||
Cash Ratio | 6.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.6 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -63.39 | |||||
ROA % | -42.16 | |||||
ROIC % | -168.04 | |||||
ROC (Joel Greenblatt) % | -234.61 | |||||
ROCE % | -46.38 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.05 | |||||
Price-to-Tangible-Book | 1.05 | |||||
EV-to-EBIT | -0.25 | |||||
EV-to-Forward-EBIT | -0.28 | |||||
EV-to-EBITDA | -0.26 | |||||
EV-to-Forward-EBITDA | -0.3 | |||||
EV-to-FCF | -0.3 | |||||
Price-to-Net-Current-Asset-Value | 2.24 | |||||
Price-to-Net-Cash | 2.37 | |||||
Earnings Yield (Greenblatt) % | -400 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KOD
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Kodiak Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -5.91 | ||
Beta | 1.88 | ||
Volatility % | 67.78 | ||
14-Day RSI | 71.74 | ||
14-Day ATR ($) | 0.609188 | ||
20-Day SMA ($) | 5.7315 | ||
12-1 Month Momentum % | -45.22 | ||
52-Week Range ($) | 4.25 - 12.8 | ||
Shares Outstanding (Mil) | 52.36 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kodiak Sciences Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |
Kodiak Sciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Kodiak Sciences Inc Frequently Asked Questions
What is Kodiak Sciences Inc(KOD)'s stock price today?
The current price of KOD is $7.84. The 52 week high of KOD is $12.80 and 52 week low is $4.25.
When is next earnings date of Kodiak Sciences Inc(KOD)?
The next earnings date of Kodiak Sciences Inc(KOD) is 2023-08-09 Est..
Does Kodiak Sciences Inc(KOD) pay dividends? If so, how much?
Kodiak Sciences Inc(KOD) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |